Pfizer

YTD

ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.

CEO

Albert Bourla

CEOAlbert Bourla

Employees

81,000

Employees81,000

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

1849

Founded1849

Employees

81,000

Employees81,000

PFE Key Statistics

Market cap

139.75B

Market cap139.75B

Price-Earnings ratio

13.07

Price-Earnings ratio13.07

Dividend yield

6.96%

Dividend yield6.96%

Average volume

53.79M

Average volume53.79M

High today

$24.61

High today$24.61

Low today

$24.16

Low today$24.16

Open price

$24.29

Open price$24.29

Volume

36.38M

Volume36.38M

52 Week high

$30.43

52 Week high$30.43

52 Week low

$20.92

52 Week low$20.92

PFE News

Seeking Alpha 5d

Pfizer raises 2025 EPS guidance to $2.90–$3.10 while targeting margin expansion through $7.7B cost savings by 2027

Earnings Call Insights Pfizer raises 2025 EPS guidance to $2.90–$3.10 while targeting margin expansion through $7.7B cost savings by 2027 Aug. 05, 2025 4:47 PM...

Seeking Alpha 5d

Pfizer CEO says pharma execs discussed Trump’s direct-to-consumer demand

Healthcare Pfizer CEO says pharma execs discussed Trump’s direct-to-consumer demand Aug. 05, 2025 11:33 AM ET Pfizer Inc. (PFE) Stock BMY By: Dulan Lokuwithana,...

Seeking Alpha 5d

Pfizer rises as Q2 beat leads to guidance raise

Pfizer (NYSE:PFE) shares traded higher in the premarket on Tuesday after the New York-based pharma giant reported better-than-expected financials for Q2 2025 an...

Analyst ratings

58%

of 24 ratings

Buy

37.5%

Hold

58.3%

Sell

4.2%

More PFE News

CNBC 5d

Pfizer hikes 2025 profit outlook on cost cuts, strong quarterly results

Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. Pfizer on Tuesday hiked its full-year adjusted profit guidance on its c...

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.